ObjectiveHealth Announces Strategic Growth Investment from Vitruvian Partners
ObjectiveHealth, a leading integrated specialty research network and technology company, announced today that it has secured a strategic growth investment from Vitruvian Partners, a leading global growth-focused investment firm.
- ObjectiveHealth, a leading integrated specialty research network and technology company, announced today that it has secured a strategic growth investment from Vitruvian Partners, a leading global growth-focused investment firm.
- ObjectiveHealth is an innovator in clinical research, seamlessly integrating clinical trials into the practices of physicians, while deploying proprietary advanced technology to identify and recruit patients for the trials.
- Vitruvian’s investment will provide the capacity for ObjectiveHealth to expand its operations and continue its rapid pace of growth.
- “Under Colleen and Don’s leadership, ObjectiveHealth has built an innovative and disruptive platform for advancing clinical research,” said Sophie Bower-Straziota, partner at Vitruvian.